Abstract
Electron transfer flavoprotein (ETF) is a heterodimeric enzyme composed of an α-subunit and a β-subunit and contains a single equivalent of FAD per dimer. ETF deficiency can be demonstrated in individuals affected by a severe metabolic disorder, glutaric acidemia type II (GAII). In this study, we have investigated for the first time the molecular basis of β-ETF deficiency in three GAII patients: two Japanese brothers, P411 and P412, and a third unrelated patient, P485. Molecular analysis of the β-ETF gene in P411 and P412 demonstrated that both these patients are compound heterozygotes. One allele is carrying a G to A transition at nucleotide 518, causing a missense mutation at codon 164. This point mutation is maternally derived and is not detected in 42 unrelated controls. The other allele carries a G to C transversion at the first nucleotide of the intron donor site, downstream of an exon that is skipped during the splicing event. The sequence analysis of the β-ETF coding sequence in P485 showed only a C to T transition at nucleotide 488 that causes a Thr 154 to Met substitution and the elimination of a Hgal restriction site. Hgal restriction analysis on 63 unrelated controls genomic DNA demonstrated that the C488T transition identifies a polymorphic site. Finally, transfection of wild-type β-ETF cDNA into P411 fibroblasts suggests that wild-type β-ETF cDNA complements the genetic defect and restores the β-oxidation flux to normal levels.
Original language | English |
---|---|
Pages (from-to) | 429-435 |
Number of pages | 7 |
Journal | Human Molecular Genetics |
Volume | 3 |
Issue number | 3 |
Publication status | Published - Mar 1994 |
ASJC Scopus subject areas
- Genetics
- Statistics, Probability and Uncertainty
- Applied Mathematics
- Public Health, Environmental and Occupational Health
- Molecular Biology
- Genetics(clinical)